Combination therapy may offer better outcomes for patients with retinoblastoma
Researchers at The Saban Research Institute of Children's Hospital Los Angeles (CHLA) have demonstrated that targeting survivin—a protein that inhibits apoptosis or cell death—enhances the effectiveness of chemotherapy ...
Apr 15, 2016
0
0